Report: HHS, State Regulators Should Restrict Insurers From Requiring Patients To Pay a Percentage of Drug Costs
Regulators should limit how much insurers can charge for high-priced prescription drugs, according to a report released Wednesday by the American Cancer Society's Cancer Action Network. The report examined coverage for 22 cancer treatments in drug formularies for 66 health plans sold through Affordable Care Act's insurance exchanges in six states: California, Florida, Illinois, North Carolina, Texas and Washington. The report recommended that HHS and state regulators restrict insurers from requiring patients to pay a percentage of drug costs.
- "Cancer Society Asks Regulators To Limit Insurers' Charges for Key Drugs" (Appleby, "Shots," NPR, 11/19).